Prof. Dr. Hans-Jürgen Möller
Ludwig-Maximilians-Universität München
H-index: 161
Europe-Germany
Top articles of Prof. Dr. Hans-Jürgen Möller
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials | Markus Dold Hans-Jürgen Möller Hans-Peter Volz Erich Seifritz Sandra Schläfke | 2024/1 | |
Two Sides of Theory of Mind: Mental State Attribution to Moving Shapes in Paranoid Schizophrenia Is Independent of the Severity of Positive Symptoms | Brain Sciences | Christina Fuchs Sarita Silveira Thomas Meindl Richard Musil Kim Laura Austerschmidt | 2024/5 |
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo-and reference-controlled trial | European Archives of Psychiatry and Clinical Neuroscience | Siegfried Kasper Hans-Peter Volz Hans-Jürgen Möller Sandra Schläfke Stephan Klement | 2024/4/1 |
Is the serotonin hypothesis/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella review | Hans-Jürgen Möller Peter Falkai | 2023/2 | |
A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients | BMC psychiatry | Florian Seemüller Rebecca Schennach Richard Musil Michael Obermeier Mazda Adli | 2023/7/28 |
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited | European Archives of Psychiatry and Clinical Neuroscience | Lucie Bartova Markus Dold Hans-Peter Volz Erich Seifritz Hans-Jürgen Möller | 2023/2 |
Revisiting benzodiazepines (GABA Enhancers): A transdiagnostic and precision medicine approach | Stefano Pallanti Joseph Zohar Siegfried Kasper Hans-Jürgen Möller Eric Hollander | 2023/12/2 | |
The Interplay of Oxytocin and Attachment in Schizophrenic Patients: An fMRI Study | Brain Sciences | Kristina Hennig-Fast Dominik Meissner Carolin Steuwe Sandra Dehning Janusch Blautzik | 2023/7/25 |
Therapieresistenz unipolarer depressiver Erkrankung: Definition, Häufigkeit, Charakteristika, Prädiktoren und Risikofaktoren | Thomas Frodl Hans-Jürgen Möller | 2023/3/1 | |
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials | European Archives of Psychiatry and Clinical Neuroscience | Markus Dold Lucie Bartova Hans-Peter Volz Erich Seifritz Hans-Jürgen Möller | 2023/10 |
Subthreshold depression–concept, operationalisation and epidemiological data. A scoping review | Hans-Peter Volz Johanna Stirnweiß Siegfried Kasper Hans-Jürgen Möller Erich Seifritz | 2023/3/1 | |
Recollecting Hanns Hippius: a stimulating pioneer of psychopharmacology and neuroscience | International Journal of Psychiatry in Clinical Practice | Hans-Jürgen Möller | 2023/9/1 |
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders–Version 3. Part I … | Hubertus Himmerich Yael Doreen Lewis Chiara Conti Hiba Mutwalli Andreas Karwautz | 2023/9/14 | |
Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan | Siegfried Kasper Anne Eckert Hans-Jürgen Möller Hans-Peter Volz Erich Seifritz | 2023/9/1 | |
Subsyndromal generalised anxiety disorder: operationalisation and epidemiology–a systematic literature survey | Hans-Peter Volz Julia Saliger Siegfried Kasper Hans-Jürgen Möller Erich Seifritz | 2022/9/1 | |
Effect of anxiolytic drug silexan on sleep–a narrative review | Erich Seifritz Siegfried Kasper Hans-Jürgen Möller Hans-Peter Volz Walter E Müller | 2022/8/9 | |
Chronic vs non-chronic depression in psychiatric inpatient care-Data from a large naturalistic multicenter trial | Journal of Affective Disorders | Florian Seemueller Miriam Kolter Richard Musil Rebecca Schennach Mazda Adli | 2022/2/15 |
The COVID-19 pandemic: Is it a turning point for E-health?: CON | European Psychiatry | H-J Möller | 2021/4 |
The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia | CNS spectrums | Konstantinos N Fountoulakis Hans-Jurgen Moeller Siegfried Kasper Carol Tamminga Shigeto Yamawaki | 2021/12 |
Medication management of antipsychotic treatment in schizophrenia—A narrative review | Matti Isohanni Erika Jääskeläinen Brian J Miller Anja Hulkko Jari Tiihonen | 2021/3 |
